U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment Number 1 to
Form 10-QSB/A
/X/ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the quarterly period ended March 31, 1996 .
-------------------------------
/_/ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934
For the transition period from ______________ to ______________.
Commission file number 0-19827
-------
HYMEDIX, INC.
(Exact name of registrant, as specified in its charter)
Delaware 22-3279252
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2235 Route 130, Dayton, New Jersey 08810
(Address of principal executive offices, including zip code)
Registrant's telephone number, including area code: (908) 274-2288
-------------
Check whether the registrant (1) filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12
months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days.
Yes /X/ No ___
State the number of shares outstanding of each of the registrant's classes of
common stock, as of the latest practicable date.
Class Outstanding as of March 31, 1996
----- ----------------------------------
Common 5,713,500
Transitional Small Business Disclosure Format (Check one): Yes No /X/
Page 1 of 5
Exhibit Index begins on Page 4
<PAGE>
This Report on Form 10-QSB/A is being filed to include the registrant's
Financial Data Schedule, which was inadvertantly omitted from the registrant's
Report on Form 10-QSB filed on May 15, 1996.
Part II - OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits
10.1. Convertible Bond Purchase Agreement, effective February 27,
1996, by and among the Company, HYMEDIX International,
First Taiwan Investment and Development, Inc., and the
Purchasers (as defined therein).
10.2. Convertible Bond Purchase Agreement, effective March 5,
1996, by and among the Company, HYMEDIX International,
and Su Chen Huang.
27. Financial Data Schedule
Page 2 of 5
<PAGE>
SIGNATURES
In accordance with the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
HYMEDIX, INC.
(Registrant)
Date: August 13, 1996 By: /s/ Joseph Y. Peng
--------------------
Joseph Y. Peng
President (Principal Executive Officer),
Treasurer
Date: August 13, 1996 By: /s/ William G. Gridley, jr.
-----------------------------
William G. Gridley, jr.
Chief Financial Officer (Principal
Financial Officer and Principal
Accounting Officer)
Secretary, Director
Page 3 of 5
<PAGE>
TABLE OF EXHIBITS
Exhibit No. Page Number
- ---------- -----------
*10.1. Convertible Bond Purchase Agreement, effective February 27,
1996, by and among the Company, HYMEDIX International,
First Taiwan Investment and Development, Inc., and the
Purchasers (as defined therein).
*10.2. Convertible Bond Purchase Agreement, effective March 5,
1996, by and among the Company, HYMEDIX International,
and Su Chen Huang.
27. Financial Data Schedule 5
*Previously filed as exhibits to the Company's Report on Form 10-QSB
for quarter ended March 31, 1996.
Page 4 of 5
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1
<CURRENCY> U.S. Dollar
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1996
<PERIOD-START> JAN-1-1996
<PERIOD-END> MAR-31-1996
<EXCHANGE-RATE> 1
<CASH> 109,339
<SECURITIES> 0
<RECEIVABLES> 138,941
<ALLOWANCES> 0
<INVENTORY> 412,541
<CURRENT-ASSETS> 763,843
<PP&E> 839,218
<DEPRECIATION> 655,895
<TOTAL-ASSETS> 1,095,703
<CURRENT-LIABILITIES> 5,133,904
<BONDS> 150,000
0
30,572
<COMMON> 5,713
<OTHER-SE> (4,224,486)
<TOTAL-LIABILITY-AND-EQUITY> 1,095,703
<SALES> 699,485
<TOTAL-REVENUES> 699,485
<CGS> 224,712
<TOTAL-COSTS> 921,269
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 49,824
<INCOME-PRETAX> (271,094)
<INCOME-TAX> 0
<INCOME-CONTINUING> (271,094)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (271,094)
<EPS-PRIMARY> (.05)
<EPS-DILUTED> (.05)
</TABLE>
